Blog
Bioprocess Scale Down Model (SDM) vs Commercial scale: Introduction, Limitations and Goals
Feb 26, 2026 455
Scale Down Model (SDM) for Bioprocess: Equivalence Test, Outcome, Benefits and Conclusion
Feb 26, 2026 410
Scale Down Model (SDM) for Bioprocess: Equivalence acceptable criteria (EAC)/Practical significant difference (PSD) & Sample Size Calculation
Feb 26, 2026 418
Cell Culture Data Analytics Flow
Feb 26, 2026 446
Bioreactor Scale-Up Strategy: Key Concepts and Approaches
Feb 26, 2026 372
Process Risk Assessment: A Data-Driven FMEA Approach
Feb 26, 2026 357
Design of Experiment (DoE) for Bioprocess- An Introduction
Feb 26, 2026 319
Design of Experiment (DoE) for Bioprocess-Design Evaluation Guide
Feb 26, 2026 304
Blocking in DoE in Bioprocess Development: A Practical and Statistical Perspective
Feb 26, 2026 11
An Introduction to Hybrid Modelling: Concept and Workflow
Feb 26, 2026 5
Tell Us About Your Project
Our team of experienced professionals at Graphtal is ready to transform your project from idea to
reality, ensuring alignment with your organisation goals through advanced data analytics and
predictive modelling.
Let's simplify your work